EP3003044A1 - Sophorolipides modifiés utilisables en tant qu'agents de solubilisation des huiles - Google Patents
Sophorolipides modifiés utilisables en tant qu'agents de solubilisation des huilesInfo
- Publication number
- EP3003044A1 EP3003044A1 EP14803556.1A EP14803556A EP3003044A1 EP 3003044 A1 EP3003044 A1 EP 3003044A1 EP 14803556 A EP14803556 A EP 14803556A EP 3003044 A1 EP3003044 A1 EP 3003044A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oil
- sophorolipid
- modified
- natural
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002904 solvent Substances 0.000 title claims description 23
- 239000000203 mixture Substances 0.000 claims abstract description 95
- 150000001875 compounds Chemical class 0.000 claims abstract description 58
- 238000000034 method Methods 0.000 claims abstract description 45
- 238000004945 emulsification Methods 0.000 claims abstract description 23
- 238000005063 solubilization Methods 0.000 claims abstract description 18
- 230000007928 solubilization Effects 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 14
- 239000006185 dispersion Substances 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 9
- ZTOKUMPYMPKCFX-CZNUEWPDSA-N (E)-17-[(2R,3R,4S,5S,6R)-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxyoctadec-9-enoic acid Chemical class OC(=O)CCCCCCC/C=C/CCCCCCC(C)O[C@@H]1O[C@H](COC(C)=O)[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O1 ZTOKUMPYMPKCFX-CZNUEWPDSA-N 0.000 claims description 96
- 239000003921 oil Substances 0.000 claims description 91
- 235000019198 oils Nutrition 0.000 claims description 89
- 239000004094 surface-active agent Substances 0.000 claims description 47
- -1 makeup Substances 0.000 claims description 44
- 230000000694 effects Effects 0.000 claims description 32
- 239000003995 emulsifying agent Substances 0.000 claims description 31
- 238000009472 formulation Methods 0.000 claims description 29
- 150000001408 amides Chemical class 0.000 claims description 26
- 239000000194 fatty acid Substances 0.000 claims description 23
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 22
- 229930195729 fatty acid Natural products 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 17
- 239000000575 pesticide Substances 0.000 claims description 17
- 239000002270 dispersing agent Substances 0.000 claims description 16
- 229940060367 inert ingredients Drugs 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 239000003876 biosurfactant Substances 0.000 claims description 13
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 11
- 125000005842 heteroatom Chemical group 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 230000000845 anti-microbial effect Effects 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
- 229940024606 amino acid Drugs 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 7
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 125000005207 tetraalkylammonium group Chemical group 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 6
- 102000015636 Oligopeptides Human genes 0.000 claims description 6
- 108010038807 Oligopeptides Proteins 0.000 claims description 6
- 239000004599 antimicrobial Substances 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 230000007613 environmental effect Effects 0.000 claims description 6
- 125000000524 functional group Chemical group 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 6
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 5
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 claims description 4
- 238000005906 dihydroxylation reaction Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 3
- 235000019485 Safflower oil Nutrition 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- XJLXLCWHYSPAJZ-UHFFFAOYSA-N dithiirane Chemical compound C1SS1 XJLXLCWHYSPAJZ-UHFFFAOYSA-N 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 150000002334 glycols Chemical class 0.000 claims description 3
- 238000006197 hydroboration reaction Methods 0.000 claims description 3
- 238000005984 hydrogenation reaction Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- 239000012285 osmium tetroxide Substances 0.000 claims description 3
- 229910000489 osmium tetroxide Inorganic materials 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 239000000123 paper Substances 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 229920001451 polypropylene glycol Polymers 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 2
- 229930186217 Glycolipid Natural products 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 2
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 229940049920 malate Drugs 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000003305 oil spill Substances 0.000 claims description 2
- 239000010502 orange oil Substances 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims 10
- 239000002671 adjuvant Substances 0.000 claims 6
- 239000003826 tablet Substances 0.000 claims 6
- 239000000843 powder Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 230000000853 biopesticidal effect Effects 0.000 claims 4
- 239000006172 buffering agent Substances 0.000 claims 4
- 239000003002 pH adjusting agent Substances 0.000 claims 4
- 230000000361 pesticidal effect Effects 0.000 claims 4
- 239000002689 soil Substances 0.000 claims 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 3
- 239000008187 granular material Substances 0.000 claims 3
- 239000006072 paste Substances 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 239000000872 buffer Substances 0.000 claims 2
- 239000012459 cleaning agent Substances 0.000 claims 2
- 239000003240 coconut oil Substances 0.000 claims 2
- 235000019864 coconut oil Nutrition 0.000 claims 2
- 239000003623 enhancer Substances 0.000 claims 2
- 150000002118 epoxides Chemical class 0.000 claims 2
- 239000007888 film coating Substances 0.000 claims 2
- 238000009501 film coating Methods 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 2
- 239000004006 olive oil Substances 0.000 claims 2
- 235000008390 olive oil Nutrition 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 239000002304 perfume Substances 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 2
- UJEADPSEBDCWPS-SGJODSJKSA-N (2R,3R)-1-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]butane-1,2,3,4-tetrol Chemical compound C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)C([C@H](O)[C@H](O)CO)O UJEADPSEBDCWPS-SGJODSJKSA-N 0.000 claims 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 claims 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 235000019489 Almond oil Nutrition 0.000 claims 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 claims 1
- 229920002101 Chitin Polymers 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 235000019499 Citrus oil Nutrition 0.000 claims 1
- 235000005976 Citrus sinensis Nutrition 0.000 claims 1
- 240000002319 Citrus sinensis Species 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- DSLZVSRJTYRBFB-LLEIAEIESA-L D-glucarate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O DSLZVSRJTYRBFB-LLEIAEIESA-L 0.000 claims 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- 108010028921 Lipopeptides Proteins 0.000 claims 1
- 102000004895 Lipoproteins Human genes 0.000 claims 1
- 108090001030 Lipoproteins Proteins 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims 1
- 235000006679 Mentha X verticillata Nutrition 0.000 claims 1
- 235000002899 Mentha suaveolens Nutrition 0.000 claims 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims 1
- IOSXSVZRTUWBHC-LBTVDEKVSA-N Quassin Chemical compound CC([C@@H]1CC(=O)O[C@@H]([C@]21C)C1)=C(OC)C(=O)[C@@H]2[C@]2(C)[C@@H]1[C@H](C)C=C(OC)C2=O IOSXSVZRTUWBHC-LBTVDEKVSA-N 0.000 claims 1
- 235000003434 Sesamum indicum Nutrition 0.000 claims 1
- 244000040738 Sesamum orientale Species 0.000 claims 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 235000019486 Sunflower oil Nutrition 0.000 claims 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 claims 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 claims 1
- 229940022663 acetate Drugs 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 230000002411 adverse Effects 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 239000008168 almond oil Substances 0.000 claims 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical class [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 claims 1
- 239000000908 ammonium hydroxide Substances 0.000 claims 1
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 229940009098 aspartate Drugs 0.000 claims 1
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 claims 1
- 239000010624 camphor oil Substances 0.000 claims 1
- 229960000411 camphor oil Drugs 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 239000010627 cedar oil Substances 0.000 claims 1
- 150000001773 cellobioses Chemical class 0.000 claims 1
- 229960000541 cetyl alcohol Drugs 0.000 claims 1
- 229940117916 cinnamic aldehyde Drugs 0.000 claims 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 claims 1
- 239000010630 cinnamon oil Substances 0.000 claims 1
- 229940001468 citrate Drugs 0.000 claims 1
- 239000010632 citronella oil Substances 0.000 claims 1
- 239000010500 citrus oil Substances 0.000 claims 1
- 239000010634 clove oil Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 235000005687 corn oil Nutrition 0.000 claims 1
- 239000002285 corn oil Substances 0.000 claims 1
- 239000002385 cottonseed oil Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- VWTINHYPRWEBQY-UHFFFAOYSA-N denatonium Chemical compound [O-]C(=O)C1=CC=CC=C1.C=1C=CC=CC=1C[N+](CC)(CC)CC(=O)NC1=C(C)C=CC=C1C VWTINHYPRWEBQY-UHFFFAOYSA-N 0.000 claims 1
- 229960001610 denatonium benzoate Drugs 0.000 claims 1
- 239000002781 deodorant agent Substances 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims 1
- 238000007598 dipping method Methods 0.000 claims 1
- 238000004851 dishwashing Methods 0.000 claims 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 claims 1
- 239000000428 dust Substances 0.000 claims 1
- 238000010410 dusting Methods 0.000 claims 1
- 239000010642 eucalyptus oil Substances 0.000 claims 1
- 229940044949 eucalyptus oil Drugs 0.000 claims 1
- 230000001815 facial effect Effects 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 235000021323 fish oil Nutrition 0.000 claims 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 claims 1
- 239000010647 garlic oil Substances 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 235000019717 geranium oil Nutrition 0.000 claims 1
- 239000010648 geranium oil Substances 0.000 claims 1
- 229940050410 gluconate Drugs 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 229940068939 glyceryl monolaurate Drugs 0.000 claims 1
- 229930182470 glycoside Natural products 0.000 claims 1
- 235000011167 hydrochloric acid Nutrition 0.000 claims 1
- ROBFUDYVXSDBQM-UHFFFAOYSA-L hydroxymalonate(2-) Chemical compound [O-]C(=O)C(O)C([O-])=O ROBFUDYVXSDBQM-UHFFFAOYSA-L 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 229940001447 lactate Drugs 0.000 claims 1
- 239000007934 lip balm Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 229940127554 medical product Drugs 0.000 claims 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
- 235000019799 monosodium phosphate Nutrition 0.000 claims 1
- 238000000465 moulding Methods 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 229940051866 mouthwash Drugs 0.000 claims 1
- 229940043348 myristyl alcohol Drugs 0.000 claims 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims 1
- 229910017604 nitric acid Inorganic materials 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 229940039748 oxalate Drugs 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 235000019477 peppermint oil Nutrition 0.000 claims 1
- 239000003090 pesticide formulation Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical class OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000010665 pine oil Substances 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 150000007519 polyprotic acids Chemical class 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 235000011181 potassium carbonates Nutrition 0.000 claims 1
- 235000011118 potassium hydroxide Nutrition 0.000 claims 1
- 239000012254 powdered material Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- IOSXSVZRTUWBHC-UHFFFAOYSA-N quassin Natural products C1C(C23C)OC(=O)CC3C(C)=C(OC)C(=O)C2C2(C)C1C(C)C=C(OC)C2=O IOSXSVZRTUWBHC-UHFFFAOYSA-N 0.000 claims 1
- 230000015227 regulation of liquid surface tension Effects 0.000 claims 1
- 239000010668 rosemary oil Substances 0.000 claims 1
- 229940058206 rosemary oil Drugs 0.000 claims 1
- 239000010670 sage oil Substances 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 239000008257 shaving cream Substances 0.000 claims 1
- 239000002884 skin cream Substances 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 235000017550 sodium carbonate Nutrition 0.000 claims 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 235000011008 sodium phosphates Nutrition 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 229940012831 stearyl alcohol Drugs 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 239000002600 sunflower oil Substances 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 claims 1
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 239000003760 tallow Substances 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims 1
- 239000010678 thyme oil Substances 0.000 claims 1
- 229940034610 toothpaste Drugs 0.000 claims 1
- 239000000606 toothpaste Substances 0.000 claims 1
- 150000003625 trehaloses Chemical class 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 239000008158 vegetable oil Substances 0.000 claims 1
- 239000001993 wax Substances 0.000 claims 1
- 239000004563 wettable powder Substances 0.000 claims 1
- 239000009637 wintergreen oil Substances 0.000 claims 1
- 239000003054 catalyst Substances 0.000 abstract description 8
- 108090000790 Enzymes Proteins 0.000 abstract description 5
- 102000004190 Enzymes Human genes 0.000 abstract description 5
- 239000002417 nutraceutical Substances 0.000 abstract description 4
- 235000021436 nutraceutical agent Nutrition 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 239000000839 emulsion Substances 0.000 description 132
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 93
- 229910001868 water Inorganic materials 0.000 description 87
- 239000012071 phase Substances 0.000 description 41
- 239000005662 Paraffin oil Substances 0.000 description 30
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 22
- 230000002378 acidificating effect Effects 0.000 description 18
- 230000008859 change Effects 0.000 description 18
- 230000032683 aging Effects 0.000 description 17
- 235000019501 Lemon oil Nutrition 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- 239000010501 lemon oil Substances 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000010779 crude oil Substances 0.000 description 14
- 230000003247 decreasing effect Effects 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 9
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 9
- 238000006073 displacement reaction Methods 0.000 description 9
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 239000012188 paraffin wax Substances 0.000 description 8
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 8
- 125000003152 sophorose group Chemical group 0.000 description 8
- 239000007762 w/o emulsion Substances 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- 239000000693 micelle Substances 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 241001278026 Starmerella bombicola Species 0.000 description 6
- 230000003466 anti-cipated effect Effects 0.000 description 6
- 240000002791 Brassica napus Species 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 125000005907 alkyl ester group Chemical group 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000000265 homogenisation Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 4
- 235000011293 Brassica napus Nutrition 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 239000012039 electrophile Substances 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000007764 o/w emulsion Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- UMIZOHMCQYCZRX-IHWYPQMZSA-N (9Z)-17-hydroxyoctadec-9-enoic acid Chemical compound CC(O)CCCCCC\C=C/CCCCCCCC(O)=O UMIZOHMCQYCZRX-IHWYPQMZSA-N 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- UMIZOHMCQYCZRX-UHFFFAOYSA-N 17-hydroxyoleic acid Natural products CC(O)CCCCCCC=CCCCCCCCC(O)=O UMIZOHMCQYCZRX-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 3
- BGAJNPLDJJBRHK-UHFFFAOYSA-N 3-[2-[5-(3-chloro-4-propan-2-yloxyphenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-5-yl]propanoic acid Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1C1=NN=C(N2C(=C3CN(CCC(O)=O)CCC3=N2)C)S1 BGAJNPLDJJBRHK-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000009470 Theobroma cacao Nutrition 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 3
- 230000021736 acetylation Effects 0.000 description 3
- 238000006640 acetylation reaction Methods 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical compound [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 3
- MRABAEUHTLLEML-LURJTMIESA-N butyl (2s)-2-hydroxypropanoate Chemical compound CCCCOC(=O)[C@H](C)O MRABAEUHTLLEML-LURJTMIESA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- XQKKWWCELHKGKB-UHFFFAOYSA-L calcium acetate monohydrate Chemical compound O.[Ca+2].CC([O-])=O.CC([O-])=O XQKKWWCELHKGKB-UHFFFAOYSA-L 0.000 description 3
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 229940125846 compound 25 Drugs 0.000 description 3
- 238000005686 cross metathesis reaction Methods 0.000 description 3
- SHFGJEQAOUMGJM-UHFFFAOYSA-N dialuminum dipotassium disodium dioxosilane iron(3+) oxocalcium oxomagnesium oxygen(2-) Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Al+3].[Al+3].[K+].[K+].[Fe+3].[Fe+3].O=[Mg].O=[Ca].O=[Si]=O SHFGJEQAOUMGJM-UHFFFAOYSA-N 0.000 description 3
- 125000004185 ester group Chemical group 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- ALBYIUDWACNRRB-UHFFFAOYSA-N hexanamide Chemical compound CCCCCC(N)=O ALBYIUDWACNRRB-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- WKZJASQVARUVAW-UHFFFAOYSA-M potassium;hydron;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].OC(=O)CC(O)(C(O)=O)CC([O-])=O WKZJASQVARUVAW-UHFFFAOYSA-M 0.000 description 3
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- FCBUKWWQSZQDDI-UHFFFAOYSA-N rhamnolipid Chemical compound CCCCCCCC(CC(O)=O)OC(=O)CC(CCCCCCC)OC1OC(C)C(O)C(O)C1OC1C(O)C(O)C(O)C(C)O1 FCBUKWWQSZQDDI-UHFFFAOYSA-N 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 102100039981 Hairy and enhancer of split-related protein HELT Human genes 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 101001034987 Homo sapiens Hairy and enhancer of split-related protein HELT Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 241001514713 Pseudohyphozyma bogoriensis Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241001149679 [Candida] apicola Species 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- OKSRBEMKUSZPOX-UHFFFAOYSA-N aluminum;sodium;silicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])([O-])[O-] OKSRBEMKUSZPOX-UHFFFAOYSA-N 0.000 description 2
- VWSRWGFGAAKTQG-UHFFFAOYSA-N ammonium benzoate Chemical compound [NH4+].[O-]C(=O)C1=CC=CC=C1 VWSRWGFGAAKTQG-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- NSQPPSOSXWOZNH-UHFFFAOYSA-L calcium benzoate Chemical compound [Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 NSQPPSOSXWOZNH-UHFFFAOYSA-L 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- JHLNERQLKQQLRZ-UHFFFAOYSA-N calcium silicate Chemical compound [Ca+2].[Ca+2].[O-][Si]([O-])([O-])[O-] JHLNERQLKQQLRZ-UHFFFAOYSA-N 0.000 description 2
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 description 2
- NDWWLJQHOLSEHX-UHFFFAOYSA-L calcium;octanoate Chemical compound [Ca+2].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O NDWWLJQHOLSEHX-UHFFFAOYSA-L 0.000 description 2
- 235000019519 canola oil Nutrition 0.000 description 2
- 239000000828 canola oil Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 238000004581 coalescence Methods 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- ONCZQWJXONKSMM-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4].[Si+4].[Si+4].[Si+4] ONCZQWJXONKSMM-UHFFFAOYSA-N 0.000 description 2
- DGVMNQYBHPSIJS-UHFFFAOYSA-N dimagnesium;2,2,6,6-tetraoxido-1,3,5,7-tetraoxa-2,4,6-trisilaspiro[3.3]heptane;hydrate Chemical compound O.[Mg+2].[Mg+2].O1[Si]([O-])([O-])O[Si]21O[Si]([O-])([O-])O2 DGVMNQYBHPSIJS-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 230000003028 elevating effect Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 230000002431 foraging effect Effects 0.000 description 2
- 244000000004 fungal plant pathogen Species 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- PJJZFXPJNUVBMR-UHFFFAOYSA-L magnesium benzoate Chemical compound [Mg+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 PJJZFXPJNUVBMR-UHFFFAOYSA-L 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000007908 nanoemulsion Substances 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 150000002924 oxiranes Chemical class 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000010451 perlite Substances 0.000 description 2
- 235000019362 perlite Nutrition 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- MLICVSDCCDDWMD-KVVVOXFISA-M potassium;(z)-octadec-9-enoate Chemical compound [K+].CCCCCCCC\C=C/CCCCCCCC([O-])=O MLICVSDCCDDWMD-KVVVOXFISA-M 0.000 description 2
- RLEFZEWKMQQZOA-UHFFFAOYSA-M potassium;octanoate Chemical compound [K+].CCCCCCCC([O-])=O RLEFZEWKMQQZOA-UHFFFAOYSA-M 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229940073450 sudan red Drugs 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BPYWNJQNVNYQSQ-UHFFFAOYSA-N (3-decanoyloxy-2-hydroxypropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCC BPYWNJQNVNYQSQ-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- QHGUCRYDKWKLMG-QMMMGPOBSA-N (R)-octopamine Chemical compound NC[C@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-QMMMGPOBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- JFBCSFJKETUREV-UHFFFAOYSA-N 1,2 ditetradecanoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCC JFBCSFJKETUREV-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- RUKVGXGTVPPWDD-UHFFFAOYSA-N 1,3-bis(2,4,6-trimethylphenyl)imidazolidine Chemical group CC1=CC(C)=CC(C)=C1N1CN(C=2C(=CC(C)=CC=2C)C)CC1 RUKVGXGTVPPWDD-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical class OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-CQSZACIVSA-N 1-Monolaurin Natural products CCCCCCCCCCCC(=O)OC[C@H](O)CO ARIWANIATODDMH-CQSZACIVSA-N 0.000 description 1
- DCBSHORRWZKAKO-MRXNPFEDSA-N 1-Monomyristin Natural products CCCCCCCCCCCCCC(=O)OC[C@H](O)CO DCBSHORRWZKAKO-MRXNPFEDSA-N 0.000 description 1
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- KWIPUXXIFQQMKN-UHFFFAOYSA-N 2-azaniumyl-3-(4-cyanophenyl)propanoate Chemical compound OC(=O)C(N)CC1=CC=C(C#N)C=C1 KWIPUXXIFQQMKN-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241001163841 Albugo ipomoeae-panduratae Species 0.000 description 1
- 238000006596 Alder-ene reaction Methods 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241001480052 Aspergillus japonicus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000237369 Helix pomatia Species 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 238000006469 Jacobsen epoxidation reaction Methods 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 101100351020 Mus musculus Pax5 gene Proteins 0.000 description 1
- 241000700110 Myocastor coypus Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- QHGUCRYDKWKLMG-MRVPVSSYSA-N Octopamine Natural products NC[C@@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-MRVPVSSYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 102100037504 Paired box protein Pax-5 Human genes 0.000 description 1
- 101710149067 Paired box protein Pax-5 Proteins 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 241000985535 Penicillium decumbens Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 241000233616 Phytophthora capsici Species 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241001136494 Talaromyces funiculosus Species 0.000 description 1
- 101100351021 Xenopus laevis pax5 gene Proteins 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- YCNZFPXXIWEFCF-UHFFFAOYSA-N alumane;sodium Chemical compound [Na].[AlH3] YCNZFPXXIWEFCF-UHFFFAOYSA-N 0.000 description 1
- SXQXMCWCWVCFPC-UHFFFAOYSA-N aluminum;potassium;dioxido(oxo)silane Chemical compound [Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O SXQXMCWCWVCFPC-UHFFFAOYSA-N 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 229940090948 ammonium benzoate Drugs 0.000 description 1
- 229940088990 ammonium stearate Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 125000000656 azaniumyl group Chemical group [H][N+]([H])([H])[*] 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- NNBFNNNWANBMTI-UHFFFAOYSA-M brilliant green Chemical compound OS([O-])(=O)=O.C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 NNBFNNNWANBMTI-UHFFFAOYSA-M 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229940067460 calcium acetate monohydrate Drugs 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Inorganic materials [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 239000011153 ceramic matrix composite Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000012710 chemistry, manufacturing and control Methods 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- 229940040387 citrus pectin Drugs 0.000 description 1
- 239000009194 citrus pectin Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- FTGQJXZCUXNQRD-UHFFFAOYSA-N dialuminum dipotassium disodium dioxido(oxo)silane Chemical compound [Na+].[Na+].[Al+3].[Al+3].[K+].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O FTGQJXZCUXNQRD-UHFFFAOYSA-N 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- PFKGDYCESFRMAP-UHFFFAOYSA-L dicalcium citrate Chemical compound [Ca+2].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O PFKGDYCESFRMAP-UHFFFAOYSA-L 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- FBPXRCLDUZKJLC-UHFFFAOYSA-N dioxosilane;oxomagnesium Chemical compound [Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FBPXRCLDUZKJLC-UHFFFAOYSA-N 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- BLCTWBJQROOONQ-UHFFFAOYSA-N ethenyl prop-2-enoate Chemical compound C=COC(=O)C=C BLCTWBJQROOONQ-UHFFFAOYSA-N 0.000 description 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 108010066429 galactomannanase Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000011507 gypsum plaster Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010030923 hesperidinase Proteins 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052909 inorganic silicate Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 108010090785 inulinase Proteins 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-N methyl hydrogen carbonate Chemical compound COC(O)=O CXHHBNMLPJOKQD-UHFFFAOYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 235000015861 monopotassium citrate Nutrition 0.000 description 1
- 239000002444 monopotassium citrate Substances 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 108010001078 naringinase Proteins 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960001576 octopamine Drugs 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229940096992 potassium oleate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000005834 sharpless asymmetric dihydroxylation reaction Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- GYBMSOFSBPZKCX-UHFFFAOYSA-N sodium;ethanol;ethanolate Chemical compound [Na+].CCO.CC[O-] GYBMSOFSBPZKCX-UHFFFAOYSA-N 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 150000003396 sophoroses Chemical class 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical group [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- MLGCXEBRWGEOQX-UHFFFAOYSA-N tetradifon Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC(Cl)=C(Cl)C=C1Cl MLGCXEBRWGEOQX-UHFFFAOYSA-N 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000004014 thioethyl group Chemical group [H]SC([H])([H])C([H])([H])* 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/56—Glucosides; Mucilage; Saponins
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/221—Mono, di- or trisaccharides or derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2096—Heterocyclic compounds
Definitions
- the present invention relates generally to the field of sophorolipids (SL) and more specifically to new compositions of matter for uses of modified sophorolipids (MSL) and combination of sophorolipids as solubilizing agents, emulsifiers, dispersants and thereof.
- SL sophorolipids
- MSL modified sophorolipids
- sophorolipids as solubilizing agents, emulsifiers, dispersants and thereof.
- Sophorolipids are glycolipid biosurfactant molecules produced by yeasts, such as Candida bombicola, Yarrowi alipolytica, Candida apicola, and Candida bogoriensis.
- Microbial biosurfactants are surface active compounds produced by various microorganisms. They lower surface and interfacial tension and form spherical micelles at and above their critical micelle concentration (CMC).
- CMC critical micelle concentration
- Microbial biosurfactants generally have an amphiphilic structure, possessing a hydrophilic moiety, such as an amino acid, peptide, sugar or oligosaccharide, and a hydrophobic moiety including saturated or unsaturated lipid or fatty acids.
- SLs consist of a hydrophilic carbohydrate head, sophorose, and a hydrophobic fatty acid tail with generally 16 or 18 carbon atoms with saturation or un- saturation.
- Sophorose is an unusual disaccharide that consists of two glucose molecules linked ⁇ -1 ,2.
- sophorose in SLs can be acetylated on the 6'- and/or 6"- positions (FIG. 1 ).
- One fatty acid hydroxylated at the terminal or subterminal ( ⁇ -1 ) positions is ⁇ -glycosidically linked to the sophorose molecule.
- the fatty acid carboxylic acid group is either free (acidic or open form) or internally esterified generally at the 4"-position (lactonic form) (FIG.
- the hydroxy fatty acid component of SLs generally has 16 or 18 carbon atoms with generally one unsaturated bond (Asmer et al. 1988; Davila et al. 1993). However, the SL hydroxy fatty acid can also be fully saturated, di-unsaturated or tri-unsaturated. As such, SLs synthesized by C. bombicola consist of a mixture of related molecules. Differences between these molecules are found based on: i) the fatty acid structure (degree of unsaturation, chain length, and position of hydroxylation), whether they are produced in the lactonic or ring-opened form, and ii) the acetylation pattern.
- lactonic and acidic SLs are synthesized in vivo from stearic acid with similar yields to oleic acid-derived SLs (Felse et al. 2007).
- physiological variables during fermentations have provided routes to the variation of SL compositions.
- sophorolipids of different structure As noted above, fermentation by different microorganisms, Candida bombicola, Yarrowi alipolytica, Candida apicola, and Candida bogoriensis, leads to sophorolipids of different structure noted above, the variations in sophorolipids based on fatty acid feedstocks and organisms leads to a wide array of sophorolipids including lactonic and acidic structures.
- An additional modification that is relevant to acidic sophorolipids is cleavage of the sophorose moiety to the corresponding glucose-based glucolipids.
- CMC decreased to 1/2 per additional CH 2 group for the methyl, ethyl, and propyl series of chain lengths.
- fluorescence spectroscopy Adsorption of SL alkyl esters on hydrophilic solids was also studied to explore the type of lateral associations. These surfactants were found to absorb on alumina but much less on silica. This adsorption behavior on hydrophilic solids is similar to that of sugar-based nonionic surfactants and unlike that of nonionic ethoxylated surfactants. Hydrogen bonding is proposed to be the primary driving force for adsorption of the sophorolipids on alumina. Increase in the n-alkyl ester chain length of SLs caused a shift of the adsorption isotherms to lower concentrations. The magnitude of the shift corresponds to the change in CMC of these surfactants.
- MSLs modified sophorolipids
- MSLs have antibacterial, antiviral, and anti-inflammatory properties
- MSLs were shown to down-regulate expression of pro-inflammatory cytokines including interleukin (Hagler et al. 2007).
- the antibacterial activity of SLs can be increased by up to 1 ,000 times relative to the natural SL mixture by simple modifications such as esterification of fatty acid carboxyl groups and selective acetylation of disacchahde hydroxyl groups.
- Table 1 comprises a table of sophorolipid derivatives and sophorolipid components of the natural mixture used in bacterial and fungal plant pathogen assays.
- the hydroxylated fatty acid of the natural mixture is predominantly 17-hydroxyoleic acid. However, other fatty acid constituents with variations in chain length and unsaturation may also be present.
- modified SLs e.g., compound 6 with 7
- modified sophorolipids with natural sophorolipids
- mixture antimicrobial activity US Patent Application No. 13757762
- mixing modified SLs or a modified sophorolipids with a natural sophorolipids can result in enhanced performance properties for other applications.
- unexpected enhanced performance in specific applications may be discovered by exploring the properties of a modified sophorolipid library.
- US Patent Publication. No. 2010/0098821 A1 discloses a process that solubilizes essential oils to produce clear beverages using ionic and non-ionic emulsifiers.
- the process described in this invention simplifies the introduction of normally insoluble nutraceuticals, particularly lipophilic ones, into beverages.
- Many ionic and non-ionic surfactants were described for use in formation of these emulsions such as sorbitan esters, polyglycerol esters, monoglyceride esters, diglyceride esters, polyethylene glycol esters, sucrose esters, dioctyl sodium sulfosuccinate and lecithin. Neither modified nor natural sophorolipids are mentioned in US Patent Publication. No.
- composition of a flavor oil depends on its origin and processing, the most effective compounds for its solubilization cannot be anticipated by one skilled in the art.
- availability of safe and effective compounds that prove useful for solubilization of various flavor and fragrance oil compositions are highly useful to formulators.
- This present disclosure provides methods for the formulation of micro- and nanoemulsions using one or mixtures of modified sophorolipids, mixtures of modified sophorolipids and natural sophorolipids, as well as mixtures containing one or move modified and/or natural sophorolipid with other molecules that are already known by one skilled in the art as being useful for solubilization of flavor and fragrance oils.
- US patent No 6,214,957 B1 disclosed the use of solubilizers, emulsifiers and dispersing agents having the effects of moisturizing the skin when used as washing agents and having the character of elevating the concentration of a material to be solubilized, emulsified or dispersed in solvents including water as compared with the case where the material is employed alone, or elevating the apparent concentration of a material to be emulsified or dispersed in solvents by increasing homogeneity of the emulsion or dispersion which contain as the active ingredient polymers obtained by polymerizing monomer compositions containing at least one hydrophilic monomer (a i.e., 2-(methacryloyloxy)ethyl-2'-(alkyl-substituted or non-substituted ammonio)ethyl phosphate) having a group represented by general formula (1 ) in the side chain, wherein R1 , R2 and R3 represent each H or C 1 -4 alky
- solubilizers, emulsifiers and dispersing agents having the effects of moisturizing the skin described in US patent No 6,214,957 B1 have no or low bio-based content and are not fully biodegradable.
- present disclosure discloses MSLs with different chemical compositions that can be used in various combinations of other compounds, are highly effective molecules for a wide range of oil types such as fragrance, flavor and nutraceuticals compounds.
- modified sophorolipids are fully or highly bio-based and are completely biodegradable when disposed in many environments including in waste-water systems.
- the present invention is on application of MSLs either alone or in formulations with combinations of compounds that can consist of other MSLs, natural SLs and other known surface active compounds for use as solubiiizing, emulsification, dispersing and surface active agents.
- MSLs, and mixtures thereof with natural and other modified sophorolipids outperform natural SLs for solubilization or emulsification of various compounds such as crude oils, hydrocarbons, and food oils.
- SLs and natural SLs that are useful in this invention and thereby incorporated herein are shown in FIGs. 1 to 1 1 , Scheme 1 and 2, and Table 1 .
- SLs that are useful in this invention include the following and their esters:
- X 1 or X 2 is oxymethyl (-CH 2 O-) or methylene (-CH 2 -);
- R 1 and/or R 2 are selected from the group of functional groups consisting of: hydrogen, acetyl, acryl, urethane, hydroxyalkyl, ether, halide, and carboxyalkyl or alkyl containing heteroatoms ( , 2 ° , and 3 ° amino, tetraalkylammonium, sulfate, phosphate).
- R 1 and/or R 2 are selected from the group consisting of: hydroxyl, amide, alkanamide, alkanamide containing heteroatoms ( , 2 ° , and 3 ° amino, tetraalkylammonium), alkylsulfate, alkylphosphate, carbohydrate, and mono- or oligopeptide.
- R 3 is a hydrogen or alkyl group
- the methods involved in performing these chemical transformations are well known to those skilled in the art;
- X 3 contains heteroatoms (e.g., O, S, NH);
- X 3 R 3 is selected from the group of functional groups consisting of: hydroxy, alkanethiolate, amide, alkanamide, alkanamide containing heteroatoms ( , 2 ° , and 3 ° amino, tetraalkylammonium), alkylsulfate, alkylphosphate, carbohydrate, and mono- or oligopeptide with 2 - 50 amino acids.
- Table 1 comprises a table of Modified Sophorolipids (MSLs) and sophorolipid components of the natural mixture incorporated for use in this invention.
- MSLs Modified Sophorolipids
- the hydroxylated fatty acid of the natural mixture is predominantly 17-hydroxyoleic acid.
- Table 2 comprises CMC values for SL-amides (from this invention) as well as SL-esters (from earlier publication in Colloids and surface 2004, 240, 75) for which surface activity but not interfacial activity was studied.
- Table 3 comprises solubility results for SL-amides (compounds 22, 23, 24, and 25), SL-esters (compounds 6, 7, 8, and16), unmodified natural SLs (compounds 1 , 2, and 3) and SDS.
- Table 4 comprises average droplet size determined by a Coulter LS 230 analyzer for paraffin oil-to-water (7:3 v/v) 24 hours after preparation stored at room temperature (25°C).
- Table 5 comprises average droplet size determined by a Coulter LS 230 analyzer for paraffin oil-to-water (7:3 v/v) emulsions aged for 3-months at room temperature (25°C).
- Table 6 comprises droplet size distribution of emulsions at different storage time for lemon oil solubilization by SL-hexyl ester (16), SL-octyl ester SL (17), SL- dodecyl ester (18), Tween 60 and Rhamnolipid.
- Table 7 comprises crude oil clearing/displacement activity of MSLs.
- Table 8 comprises crude oil emulsificalion activity of MSLs.
- Scheme 1 shows a summary of chemo-enzymatic chemistry developed to prepare a library of sophorolipid analogs (see Azim et al. 2006, Singh et al., 2003, Bisht et al, 2000, Bisht et al., 1999).
- Scheme 2 shows a synthesis of diamide derivatives from lactonic sophorolipid using transalkylidenation followed by amidation reactions.
- FIG. 1 shows the structure of lactonic and acidic forms of sophorolipid mixture produced by Candida bombicola.
- FIG. 2 shows general formulas for sophorolipids and sophorolipid analogs of the present invention.
- FIG. 3 shows natural sophorolipids in the lactonic form (Compound 2).
- FIG. 4 shows sophorolipids in the open chain (acidic) form (Compound 3).
- FIG. 5 shows representative ester derivatives of the open chain form.
- FIG. 6 shows amide and related derivatives of the open chain form.
- FIG. 9 shows peptide derivatives of the open chain form.
- FIG. 10 shows trans alkylidenation derivatives of lactonic and open chain SLs.
- FIG. 1 1 shows electrophile derivatives at sophorose ring.
- FIG. 12 shows CMC of SL-amides, SL-esters and alkyl glucoside as a function of alkyl chain length.
- FIG. 13 shows dilution test for O/W emulsions.
- FIG. 15 shows Emulsion phase separation for emulsions prepared using natural and modified sophorolipids 3 by homogenization of paraffin oil/water (5:5 volume ratio) and 2%-by-weight relative to the water phase.
- FIG. 20 shows viscosity of emulsions prepared from paraffin oil/water 7:3 v/v stabilized by 1 %-by-weight MSL or SDS as a function of aging time at room temperature (25°C).
- FIG. 21 shows viscosity of emulsions prepared from paraffin oil/water 7:3 v/v, aged for 24 hours at room temperature (25°C), as a function of MSL or SDS concentration (weight-%-relative to the oil phase).
- FIG. 23A shows a microscopic image of sample A in FIG. 1 diluted in paraffin oil that contained sudan red. The image shows that a water-in-oil emulsion formed (scale bar: 100 ⁇ ).
- FIG. 23B shows a microscopic image of sample B in FIG. 23 diluted in paraffin oil. The water-in-oil emulsion was confirmed by dilution experiment, as dye experiment gave poor resolution (scale bar: 10 ⁇ ).
- FIG. 24 shows a microscopic image of water-in-oil emulsion formed with rapeseeds oil using compound 40; picture was taken after 6 weeks and studies of the emulsion phase and emulsion droplet size shows the emulsion remained stable.
- FIG. 25 MSL combinations. Emulsions were processed with a high shear homogenizer at 13,500 rpm.
- One example of this MSL combination formulation included 5 weight% surfactant, 1 weight% lemon oil, and 94% D.I. H 2 O.
- solubilizing means obtaining a transparent or semitransparent homogenous solution when a substance to be solubilized is dissolved in a solvent.
- emulsifying means obtaining a homogenous emulsion when a substance to be emulsified is dispersed when a liquid substance and a solvent are emulsified.
- dispersing means obtaining a homogenous dispersion when a solid substance is dispersed in a solvent.
- the solubilizer, emulsifier or dispersing agent is an agent that improves solubility, emulsifying capacity or dispersion capacity of a solvent, compared to the inherent capacity of the solvent in which materials such as oils, cosmetics, pesticides, antimicrobials, hydrocarbons and drugs are dissolved, emulsified or dispersed alone.
- the present solubilizer, emulsifier or dispersing agent contains as an effective ingredient, MSL or ingredients, MSLs or combination of effective ingredients, MSLs with natural sophorolipids as solubilizers, emulsifiers, and dispersants.
- FIGs. 1 to 1 1 MSLs and natural SLs that are useful in this invention and thereby incorporated herein are shown in FIGs. 1 to 1 1 , Scheme 1 and 2, and Table 1 .
- FIGs. 1 to 1 1 MSLs and natural SLs that are useful in this invention and thereby incorporated herein are shown in FIGs. 1 to 1 1 , Scheme 1 and 2, and Table 1 .
- Table 1 MSLs and natural SLs that are useful in this invention and thereby incorporated herein are shown in FIGs. 1 to 1 1 , Scheme 1 and 2, and Table 1 .
- FIG. 2 shows the general formulas for sophorolipids and sophorolipid analogs of the present invention.
- FIG. 5 shows representative ester derivatives of the open chain form:
- FIG. 6 shows amide and related derivatives of the open chain form:
- R 3 CH 2 CH 2 OH
- R 3 CH 2 CH 2 NMe 2
- R 3 CH 2 CH 2 -(1 -Imidazole)
- FIG. 9 shows peptide derivatives of the open chain form.
- R 3 H, alkyl, aryl, heterocyclic, cationic, anionic groups.
- MSLs and combinations of MSLs described in this disclosure also include other MSL compositions that would be obvious to one skilled in the art based on review of this application or those encompassed within prior art.
- Natural SLs and MSLs suitable for use in this invention include the following chemical compositions.
- a second class of MSLs includes esterified ring-opened sophorolipids. Esterification of sophorolipids is achieved by alcoholysis of natural sophorolipid mixtures. Esters of varying chain lengths and with varying degrees of branching and containing a variety of heteroatoms are included in this invention (FIG. 5). Moreover, methods are already disclosed in the literature that describes selective acetylation of SLs at the 6'- and/or 6"-hydroxy sophorose groups. Therefore one skilled in the art will recognize that many variants may be generated by permutations of the ester functional group and sophorose acetyl groups.
- a third class of sophorolipid derivatives includes amides of acidic sophorolipids. Representative examples of sophorolipid amide derivatives are shown in FIG. 6. In the exemplary reaction shown, sophorolipid amides can be synthesized from the sophorolipid methyl ester derivative 6 by treatment with an amine at elevated temperature. It is contemplated that a variety of amines, diamines, triamines of differing chain lengths containing aliphatic, olefinic, acetylenic, and aromatic substituents can be used to synthesize the corresponding amide derivatives.
- amides derived from biogenic amines including, but not limited to, 4- aminosalicylic acid, 5-aminosalicylic acid, octopamine, 3-hydroxytyramine, phenethylamine, tryptamine, histamine, spermine, spermidine, 1 ,5-diaminopentane.
- amides bearing at the sophorose head group ionic moieties such as sulfate, sulfonate, phosphate, carboxylate and quarternary ammonium salts that result in cationic or anionic charged head groups.
- substituted amino-containing compounds can be used as a platform to expand the family of sophorolipid amides and that amino acids and polypeptides of varying chain lengths and composition can be incorporated (FIG. 9).
- a fourth class of MSL includes ammonium salts derived from SL-amides with ⁇ ', ⁇ '-dimethylamino moieties.
- An exemplary reaction is conversion of the sophorolipid ⁇ ', ⁇ '-dimethylethylamide derivative into the corresponding ammonium salt by treatment with methyl iodide at elevated temperature.
- the quaternary ammonium salt may be prepared from alkyl halides of varying chain length as well as ⁇ , ⁇ , ⁇ -diiodoalkanes, leading to the formation of a wide array of sophorolipid structures.
- a fifth class of MSLs include those modified at the sophorose 6' or 6" positions by, inter alia, an activated acyl molecule such as the vinyl ester or alkyl ester of propionic acid catalyzed by an enzyme catalyst such as a lipase in conjunction with one or more of the modifications described herein.
- an activated acyl molecule such as the vinyl ester or alkyl ester of propionic acid catalyzed by an enzyme catalyst such as a lipase in conjunction with one or more of the modifications described herein.
- an enzyme catalyst such as a lipase in conjunction with one or more of the modifications described herein.
- the unsubstituted open-chain acidic sophorolipid is acetylated at the sophorose 6'-hydroxyl position.
- carbonyl compounds of varying chain lengths and degrees of branching can be incorporated and that a variety of carbonyl-containing functional groups can be incorporated including succinate, malate and citrate.
- esters of amino acids and oligopeptides can be incorporated at the 6' and/or 6" positions of the sophorose ring.
- the 6' and/or 6" positions of the sophorose ring may be alkylated (FIG. 1 1 ) by ethylene oxide or a substituted alkylene oxide such as 2,3-epoxypropyl- 1 ,1 ,1 -trimethylammonium chloride (Quab151 ) or related electrophiles as described by Solarek (1989). Such substitutions will likely occur at the primary ( ) 6' and/or 6" positions but may also occur at the secondary (2 ° ) sophorose ring hydroxy! groups to generate mixtures of sophorolipid derivatives.
- Novel compounds in this class include alkenes with linear or branched alkyl substituents.
- combinations of metathesis (performed on either the lactonic or open chain SL) and chemical modification can be anticipated.
- the cross metathesis of lactonic sophorolipid with vinyl acrylate will produce a diester wherein each of the ester groups can be converted into the corresponding amide derivative (Scheme 2).
- a seventh class of MSLs includes MSLs synthesized using cross metathesis chemistry as described here.
- lactonic sophorolipids were dissolved in THF (0.54M) at 60°C, and then 4 mol equivalent of acrylates (with various ester chain lengths) were added along with 5 mol% M2 catalysts (1 ,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro-(3-phenyl-1 H-inden-1 - ylidene) (tricyclohexylphosphine)ruthenium(ll)). The reaction was quenched by adding ethyl vinyl ether. The conversion was higher than 90%.
- CMC critical micelle concentrations
- Example 1 CMCs of MSL esters and amides.
- FIG. 12 shows CMC of SL-amides, SL-esters and alkyl glucoside as a function of alkyl chain length.
- the SL-amide series has higher (5 to 8 times) CMC and higher MST than the corresponding SL-ester series. It appears that compared to the ester bond, the amide bond is more disruptive to organization of the corresponding MSL's.
- One skilled in the art could not have anticipated that the SL-amide n-alkyl series would have higher (5 to 8 times) CMC and higher MST than the corresponding SL-ester series.
- Amides could have provided better stabilization of micelles through strong hydrogen bonding interactions. Instead the esters pack more easily into micelles at relatively low concentration and have a lower MST than the corresponding amide analogues.
- Example 2 Emulsification activity of MSLs with paraffin oil. [0091] Emulsion type
- Dilution test In this test the emulsion is diluted either with oil (O) or water (W). If the emulsion is O/W type and it is diluted with water, it will remain stable as water is the dispersion medium. However, if the emulsion is O/W type and it is diluted with oil, the emulsion will break as oil and water are not miscible with each other. Oil-in- water emulsions can easily be diluted with an aqueous solvent whereas water-in-oil emulsions can be diluted with an oily liquid. Emulsions of the O/W type have separated layers after dilution with pure oil but form a homogenous phase when diluted by water.
- FIG. 13 shows dilution tests for O/W type emulsions.
- FIG. 13A displays two replicate test tubes with an O/W emulsion (1 ml_ total volume with water/oil ratio 5/5) stabilized by 2 weight% SL-hexyl amide (Compound 25, Table 1 ) where the oil phase was paraffin.
- FIG. 13B the tube on the left was diluted with 1 ml_ of oil whereas the tube on right was diluted with water. Visual observation of the tubes in FIG. 13B supports that the emulsions formed are indeed O/W emulsions.
- Oil Red O was applied as an oil soluble dye and emerald green as water soluble dye in the process of emulsion preparation. Observations of emulsions were made before and after staining under optical microscope at 400x magnification (FIG. 14).
- FIG. 14A shows emulsion before dye stained and
- FIG. 14B shows emulsion after dye stained by Oil Red O. From the microscopic observation, staining of the droplet center red by the oil soluble dye Oil Red O indicates the emulsion type is O/W (see FIG. 14B).
- Table 3 lists the solubility of these compounds.
- Direct comparison of SL-amides and SL-esters having identical alkyl amide and alkyl ester chain lengths showed the amides have much greater solubility. The greatest difference was for the methyl amide and methyl ester MSLs which have solubilities of >60 and ⁇ 1 mg/mL, respectively.
- the acidic SL showed good solubility (>50 mg/mL) whereas the solubility of lactonic SL was ⁇ 5 mg/mL.
- SDS had the highest solubility (>100 mg/mL). It is reasonable to assume that the insoluble fraction of compounds can still participate in the process of emulsion formation by residing at the oil-water interface.
- the paraffin oil/water volume ratio was 5/5 and the emulsifier content was 2%-by-weight relative to the water phase.
- the emulsion was obtained by homogenizing the oil and water mixture and was allowed to settle at room temperature for 24 hours. Thereafter, the volumes of the different phases in the emulsion (oil/emulsion/water) were measured (FIG. 15, which shows the results after 24 hours).
- FIG. 15 shows emulsion phase separation for emulsions prepared using natural and modified sophorolipids by homogenization of paraffin oil/water (5:5 volume ratio) and 2%-by- weight relative to the water phase.
- MA SL-Methyl Amide (22); EA: SL-Ethyl Amide (23); BA: SL-Butyl Amide (24); HA: SL-Hexyl Amide (25); ME: SL-Methyl Ester (6); EE: SL-Ethyl Ester (7); BE: SL-Butyl Ester (8); HE: SL-Hexyl Ester (16); AC: Acidic SL (3); LA: Lactonic SL (2); NA: Natural SL (1 ); SDS: Sodium dodecyl sulfate.
- Emulsions were prepared by adding 5 ml_ of paraffin oil into 5 ml_ of water containing 2%-by-weight of the emulsifier. Then, this mixture was homogenized at 13,000 rpm for 2 minutes. Thereafter, the resulting emulsion was left unagitated at 25°C for 24 hours.
- Surfactants which give a larger emulsion phase are denoted as having higher emulsion effectiveness (Process Safety and Environment protection, 2005, 83, 38-46).
- the emulsion layer increased with increase of the alkyl chain length.
- SL-esters having identical alkyl chain length as their corresponding amide derivative were more effective emulsifiers.
- ester bonds of SL-esters are less disruptive to organization at the oil water interface than amide bonds of SL-amides.
- the lactonic SL (2) was not effective in emulsification of paraffin oil under the conditions studied herein. This result could not have been anticipated by one skilled in the art.
- the acidic SL (3) gave an 8% emulsion layer, much lower than the MSL examples given herein.
- the natural SL (1 ) mixture gave a 10% emulsion layer.
- Emulsion stability with different oil/water ratio [0100] Emulsion stability with different oil/water ratio. [0101] Based on the effectiveness study, SL-butyl amide (24), hexyl amide (25), butyl ester (8), hexyl ester (16), and SDS as a reference commercial emulsifier were tested as emulsifying compounds for paraffin oil/water emulsions prepared by homogenization having different oil/water ratios. The concentration of MSLs and SDS was kept constant at 2%-by-weight relative to the water phase and the oil/water volume ratios evaluated were 1/9, 5/5 and 7/3.
- SL-esters were discovered to provide higher stabilization of the emulsification phase as a function of time than corresponding SL-amides with the same alkyl chain length. Furthermore, this invention discloses that SL-butyl ester has a better ability to stabilize the emulsion phase than SL-hexyl amide over a wide range of paraffin oil-to-water volume compositions. For example, at oil/water 5/5 (FIG. 17), using SL-butyl amide, the emulsion layer of was not observed in 3 days.
- the emulsion layer showed a small decrease in volume-% (65 to 50%) in one month. Also, at oil/water 5/5, using SL-hexyl amide, the emulsion layer decreased from 65% to 10% in one month. Surprisingly, using the SL-hexyl ester at oil/water 5/5, the emulsion layer showed only a small decrease in volume-% (70 to 65%) in one month.
- FIG. 18 emulsion formation and stability results for paraffin oil/water volume ratios of 7/3 are displayed.
- SL-butyl ester and hexyl ester formed a 95% emulsion layer, which is higher than that formed using SDS as the emulsion stabilizer (90%).
- the emulsion phases formed at this oil-to-water ratio show excellent stability.
- the emulsion phase decreased from 95% to 90 and 85%, respectively, over the one month aging period.
- Table 4 shows the average droplet size of diluted emulsions after 24 hours of preparation as a function of emulsifier concentration and MSL structure.
- Emulsified oil droplet size (average and standard deviation) was measured after suitable dilution of the emulsion phase using a Coulter LS 230 analyzer. While the particle sizes of emulsions showed no substantial change by increasing the surfactant concentration from 0.5 to 1 .0%, further increase in the surfactant concentration to 2% did result in significantly smaller emulsion drop sizes. Furthermore, for the same concentration of surfactant, emulsion oil-phase drop sizes showed no significant change for the surfactants studied in Table 4. Therefore, surprisingly, similar size emulsion phase droplets were formed for MSL's in Table 4 and SDS. Relative to natural and lactonic SL, selected MSLs show improved properties as emulsifiers on paraffin oil. These data support our development of effective MSL emulsifiers that are largely bio- based and are biodegradable in bioactive disposal systems such as waste-water treatment plants.
- emulsified oil droplet size (average and standard deviation) was measured after suitable dilution of the emulsion phase using a Coulter LS 230 analyzer and the results are listed in Table 5. Similar to results for emulsions aged for 24 hours, emulsion phase droplet size after 3-months aging showed no substantial change as the surfactant concentration increased from 0.5 to 1 .0%-by- weight with the possible exception of SL-butyl amide. However, increasing the surfactant concentration from 1 to 2% did result in substantially smaller emulsion-phase droplet sizes. Furthermore, comparing Tables 4 and 5 shows that at 1 % and 2% surfactant droplet sizes are similar for 24 hours and 3 month aging.
- MSL's can stabilize oil phases greatly decreasing their tendency to undergo coalescence.
- stabilization against coalescence by selected MSLs in this case SL-butyl ester and SL-hexyl ester, is on par with that attained using the commercial product SDS. It follows that the results of 3-month aging studies support the utility of selected MSLs for formation and stabilization of oil-in-water emulsions of paraffin oil phases.
- One skilled in the art would expect that the ability of these MSLs to stabilize paraffin oil phases teaches that they would also stabilize oil phases of similar structure.
- Viscosity was measured at 25°C with increasing shear rate from 1 S "1 to 750 S ⁇ 1 . The viscosity change was monitored for aging times up to 3 months. For all samples, the paraffin oil/water ratio is 7/3 and the surfactant concentrations studied were 0.5%, 1 % to 2%-by-weight relative to the oil phase.
- FIG. 19 presents the viscosity change with shear rate for different aging times.
- FIG. 20 shows plots of emulsion viscosity at low shear viscosity ( ⁇
- FIG. 20 shows viscosity of emulsions prepared from paraffin oil/water 7:3 stabilized by 1 %-by-weight MSL or SDS as a function of aging time at room temperature (25°C). Values of r
- the extent of viscosity decrease (from lowest to highest) with storage time was in the following order: SL-hexyl ester ⁇ SDS ⁇ SL-butyl ester ⁇ SL-hexyl amide ⁇ SL-butyl amide.
- the relative ability of different MSL structures to stabilize emulsions and thereby decrease the extent of decrease in viscosity as a function of aging time would not be predictable by one skilled in the art.
- the behavior as a function of MSL structure is related to emulsion dispersed phase droplet size. That is, the smaller the change in droplet size, the less decrease in emulsion viscosity occurs with increased aging time.
- Smaller changes in droplet size reflects the ability of the emulsifier to better stabilize particles.
- the viscosity of the emulsion stabilized by SL-butyl amide decreased by 65% (from 344 Pas to 120 Pas) whereas the viscosity of the emulsion stabilized by SL-hexyl ester decreased by 20% (from 457 Pas to 459 Pas).
- This result is consistent with the relatively better ability of SL-hexyl ester to retain a small droplet size compared to SL- butyl amide over the aging period.
- SL-hexyl ester shows almost identical properties in emulsion stability as SDS. Given the commercial importance of SDS, this shows the utility of the invention described here.
- FIG. 21 shows viscosity of emulsions prepared from paraffin oil/water 7:3, aged for 24 hours at room temperature (25°C), as a function of MSL or SDS concentration (weight-%-relative to the oil phase). The viscosity was measured 24 hours after emulsion preparation. The viscosity increased with increasing surfactant concentration. Such behavior could not have been predicted by one skilled in the art without the teaching provided in this disclosure.
- the extent of viscosity change with surfactant concentration is related to the interfacial free energy at the droplet surface that reduces with the increase of surfactant concentration.
- Example 3 Oil solubilization activity of MSLs on lemon and orange oils.
- MSL's used in this example are SL-hexyl ester (16), SL- octyl ester SL (17), and SL-dodecyl ester (18).
- MSL capacity for lemon oil solubilization, the volume ratio of water to lemon oil, the concentration of surfactant, and the homogenization time (using a sonicator as the means of homogenization) were varied. Concentration of surfactant is calculated on a w/w basis relative to the mass of water being used.
- the MSL or other surfactant is first dissolved in the water, oil is added to the solution, and finally the contents of the water/surfactant + oil system is sonicated. Subsequently, the emulsion is allowed to settle for 24 hours at 25°C before measurements or visual observations are made.
- MSL combinations were investigated. These emulsions were processed with a high shear homogenizer at 13,500 rpm.
- One example of this MSL combination formulation included 5 weight% surfactant, 1 weight% lemon oil, and 94% deionized water.
- the pure form of this formulation included 5 weight% SL-hexyl ester.
- the combination form of this formulation included 2.5 weight% SL-hexyl ester and 2.5 weight% SL-ethyl ester.
- the SL-hexyl ester emulsion after having been kept at 25°C for one week, was completely opaque, showed surfactant precipitation and possible gelling.
- FIG. 25 shows representative results of this testing.
- FIG. 25 shows MSL combinations in which FIG. 25A is 5 weight% EESL + HESL, 1 weight% Lemon Oil; and FIG. 25B is 5wt% HESL, 1wt% Lemon Oil.
- Example 4 Oil clearing/displacement activity of MSLs with crude oils.
- Oil cleaning assays were performed using Louisiana Crude, Arabian Light Crude, and Prudhoe Bay Crude as the oil phase.
- the oil clearing/displacement activity of MSLs were assessed using a crude oil layer on top of sea water in order to simulate oil spill type conditions. Sea water (20 mL) was transferred to plastic Petri dishes and 20 ⁇ of a crude oil type was added on top of the water to create an oil layer. Subsequently, a 20 ⁇ aliquot of MSL solution (1 mg/mL) was added dropwise to the top of the oil layer. The instantaneous formation of an oil clearing zone as well as the diameter of the clearing zone was determined as a function of the dispersant used.
- Example 5 Emulsification activity of MSLs with crude oils.
- Emulsification activity was assessed using Louisiana Crude, Arabian Light Crude, and Prudhoe Bay Crude as the oil phase. A 2 mL solution with emulsifier concentration of 1 mg/mL was prepared. A crude oil (10 mg) was added to the emulsifier aqueous solution, the mixture was vortexed for one minute and the emulsified mixture was allowed to stand for 20 minutes. Emulsification activity was determined by measuring turbidity of the emulsion mixture in a spectrophotometer at 610 nm.
- FIG. 23A shows a microscopic image of sample A in FIG. 1 diluted in paraffin oil that contained sudan red. The image shows that a water- in-oil emulsion formed (scale bar: 100 ⁇ ).
- FIG. 23B shows a microscopic image of sample B in FIG. 23 diluted in paraffin oil. The water-in-oil emulsion was confirmed by dilution experiment, as dye experiment gave poor resolution (scale bar: 10 ⁇ ).
- FIG. 23A shows a microscopic image of sample A in FIG. 1 diluted in paraffin oil that contained sudan red. The image shows that a water- in-oil emulsion formed (scale bar: 100 ⁇ ).
- FIG. 23B shows a microscopic image of sample B in FIG. 23 diluted in paraffin oil. The water-in-oil emulsion was confirmed by dilution experiment, as dye experiment gave poor resolution (scale bar: 10 ⁇ ).
- MSLs Modified Sophorolipids
- sophorolipid components of the natural mixture incorporated for use in this invention.
- the hydroxylated fatty acid of the natural mixture is predominantly 17-hydroxyoleic acid.
- concentration of surfactant is calculated on a w/w basis relative to the mass of water used. b) performed by dynamic light scattering
- Commonly consumed food commodities, animal feed items, and edible fats and oils as described in C 3 ⁇ 4JJiK ⁇ (a), (b), and (c) may be used as inert ingredients in FIFRA Section 25(b) pesticide products applied to food use sites (e.g., food crops, animals used for food) and in FIFRA Section 25(b) pesticide products applied to nonfood use sites (e.g., ornamental plants, highway right-of- ways, rodent control).
- Specific chemical substances listed under Q3 ⁇ 4JJCL 50(e) that are also acceptable for use as inert ingredients in FIFRA Section 25(b) pesticide products are included in the table below.
- inert ingredients are also eligible for inclusion in FIFRA Section 25(b) pesticide products. These ingredients are listed by CAS Registry Number and chemical name (common names are given, with systematic names included as synonyms in brackets where applicable). In addition, this listing has two columns to indicate whether the inert ingredient can be used in FIFRA Section 25(b) products applied to food use and/or nonfood use sites.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Cosmetics (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/902,879 US9650405B2 (en) | 2010-04-05 | 2013-05-27 | Modified sophorolipids as oil solubilizing agents |
PCT/US2014/039624 WO2014193856A1 (fr) | 2013-05-27 | 2014-05-27 | Sophorolipides modifiés utilisables en tant qu'agents de solubilisation des huiles |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3003044A1 true EP3003044A1 (fr) | 2016-04-13 |
EP3003044A4 EP3003044A4 (fr) | 2017-01-25 |
Family
ID=51989344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14803556.1A Withdrawn EP3003044A4 (fr) | 2013-05-27 | 2014-05-27 | Sophorolipides modifiés utilisables en tant qu'agents de solubilisation des huiles |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3003044A4 (fr) |
WO (1) | WO2014193856A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107926998A (zh) * | 2017-11-14 | 2018-04-20 | 张静 | 一种种衣剂的制备方法 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA45279A (fr) | 2016-03-02 | 2019-01-09 | Pathway Intermediates Ltd | Aliments pour animaux contenant des glycolipides spécifiques |
CA3105350A1 (fr) * | 2018-06-29 | 2020-01-02 | Locus Ip Company, Llc | Procede et appareil de production continue de sophorolipides |
CN112442098B (zh) * | 2019-09-03 | 2022-05-17 | 中国石油化工股份有限公司 | 一种磺化改性槐糖脂或其盐以及它们的制备方法 |
CN112742855B (zh) * | 2019-10-31 | 2022-11-15 | 中国石油化工股份有限公司 | 一种石油污染后的土壤修复方法 |
CN111096445A (zh) * | 2019-12-04 | 2020-05-05 | 江苏省农业科学院 | 一种基于微生物材料的纳米营养载体及其制备方法 |
CN114106807B (zh) * | 2020-08-27 | 2023-05-05 | 中国石油化工股份有限公司 | 一种改性槐糖脂组合物、其制备方法及应用 |
CN114479866B (zh) * | 2020-10-23 | 2024-02-09 | 中国石油化工股份有限公司 | 一种生物型淋洗剂、其制备方法及应用 |
CN114644914B (zh) * | 2020-12-17 | 2024-03-12 | 中国石油化工股份有限公司 | 一种油田降压增注剂及其制备方法和应用 |
CN114807271B (zh) * | 2022-05-06 | 2023-06-23 | 河南省科学院高新技术研究中心 | 一种发酵法制备槐糖脂的方法及槐糖脂在反渗透膜用药剂中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4999195A (en) * | 1984-10-16 | 1991-03-12 | Emulsan Biotechnologies Inc. | Personal care products containing bioemulsifiers |
US20040242501A1 (en) * | 2003-03-20 | 2004-12-02 | Gross Richard A. | Spermicidal and virucidal properties of various forms of sophorolipids |
US20050164955A1 (en) * | 2003-11-06 | 2005-07-28 | Gross Richard A. | Antifungal properties of various forms of sophorolipids |
WO2007073371A1 (fr) * | 2004-12-22 | 2007-06-28 | Polytechnic University | Sophorolipides comme inducteurs et inhibiteurs de protéines dans un milieu de fermentation |
US7718782B2 (en) * | 2005-07-26 | 2010-05-18 | The United States Of America As Represented By The Secretary Of Agriculture | Charged sophorolipids and sophorolipid containing compounds |
DE102009045077A1 (de) * | 2009-09-29 | 2011-03-31 | Evonik Goldschmidt Gmbh | Verwendung von Sophorolipiden und deren Derivaten in Kombination mit Pestiziden als Adjuvant/Additiv für den Pflanzenschutz und den industriellen non-crop Bereich |
EP2555620A4 (fr) * | 2010-04-05 | 2013-10-23 | Politechnic Inst Univ New York | Compositions d'analogues de sophorolipides |
CA2851353A1 (fr) * | 2011-10-04 | 2013-04-11 | SyntheZyme, LLC | Sophorolipides modifies pour l'inhibition de phytopathogenes |
-
2014
- 2014-05-27 WO PCT/US2014/039624 patent/WO2014193856A1/fr active Application Filing
- 2014-05-27 EP EP14803556.1A patent/EP3003044A4/fr not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO2014193856A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107926998A (zh) * | 2017-11-14 | 2018-04-20 | 张静 | 一种种衣剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP3003044A4 (fr) | 2017-01-25 |
WO2014193856A1 (fr) | 2014-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9650405B2 (en) | Modified sophorolipids as oil solubilizing agents | |
EP3003044A1 (fr) | Sophorolipides modifiés utilisables en tant qu'agents de solubilisation des huiles | |
Sałek et al. | Sustainable microbial biosurfactants and bioemulsifiers for commercial exploitation | |
de Oliveira et al. | Sophorolipids a promising biosurfactant and it’s applications | |
JP6155279B2 (ja) | 生物界面活性剤を含む毛髪および皮膚洗浄用水性組成物 | |
CA2795729C (fr) | Compositions d'analogues de sophorolipides | |
US20130142855A1 (en) | Modified sophorolipids combinations as antimicrobial agents | |
JP4891207B2 (ja) | 抗菌剤及びそれを含有する皮膚外用剤 | |
FR3040873A1 (fr) | ||
WO2014120247A1 (fr) | Combinaisons de sophorolipides modifiés en tant qu'agents antimicrobiens | |
KR101643261B1 (ko) | 리코펜 함유 조성물 | |
WO2005121294A1 (fr) | Nouvelle famille de compositions a base de polyglycosides d'alkyle et de composes derives de la glycine betaïne, utilisation comme agent tensioactif. | |
Sajna et al. | White biotechnology in biosurfactants | |
JP2000309507A (ja) | 安定な乳濁液、該乳濁液の調製方法、及びそのための試薬 | |
JP6733149B2 (ja) | 乳化組成物 | |
JP6053359B2 (ja) | 乳化組成物及びその製造方法 | |
JP5679215B2 (ja) | 逆紐状ミセルから成るオイルゲル | |
JP6192047B2 (ja) | レシチンオルガノゲル形成剤 | |
KR102129965B1 (ko) | 당류계 지방산 에스테르 제조방법 | |
US20230056021A1 (en) | Ultrafine bubble generator and ultrafine bubble generation method | |
JP5586026B2 (ja) | 逆紐状ミセルから成るオイルゲル化剤および増粘ゲル状組成物 | |
JP5582467B2 (ja) | レシチンおよび尿素を主成分とする逆紐状ミセルから成るオイルゲル | |
JP6241852B2 (ja) | レシチンオルガノゲル形成剤 | |
Wang | Biobased Colloids for Food Preservation and Fragrances Microencapsulation | |
WO2016076089A1 (fr) | Composition liquide contenant du mannosyl-érythritol-lipide b |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151126 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KOH, AMANDA Inventor name: PENG, YIFENG Inventor name: GROSS, RICHARD, A. Inventor name: RENGATHAVASI, THAVASI |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170104 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07H 15/04 20060101ALI20161222BHEP Ipc: A01N 57/12 20060101AFI20161222BHEP Ipc: C11D 3/22 20060101ALI20161222BHEP |
|
17Q | First examination report despatched |
Effective date: 20180831 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20190111 |